CYN Earnings

CYN reported its earnings on 2026-03-11, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following CYN's earnings announcement on 2026-03-11, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, CYN's stock price tends to shift by an average of 12.55% in the 10 days leading up to earnings and -13.73% in the 10 days following, providing insight into potential market.

For 2025/Q3, analysts estimate CYN's annual revenue to reach 100.00K, while the EPS is projected at -1.00. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CYN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CYN's stock price typically moves by 12.55% in the 10 days before its earnings and -13.73% in the 10 days after. For the upcoming 2025/Q3 earnings, analysts expect an EPS of -1.00 and revenue of 100.00K.

The earnings call presents a mixed picture. Product development updates are positive, but the lack of revenue and increased expenses are concerning. The Q&A reveals unclear responses, especially regarding product acceptance, adding uncertainty. The company's strong capital position offers some reassurance, but the pre-revenue status and increased operating expenses pose risks. The absence of shareholder return discussion further tempers sentiment. Overall, the positive product outlook is balanced by financial and market risks, leading to a neutral prediction.